J. Tumlin

发表

Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy

B. Rovin, J. Tumlin, C. Galphin, 2017, Kidney international reports.

Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria

Hulin Jin, J. Barratt, J. Tumlin, 2022, Kidney international reports.

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.

B. Rovin, S. Navarra, W. Pendergraft, 2019, Kidney international.

comparing the ef fi cacy and safety of dose-ranging voclosporin with p A randomized , controlled double-blind study lacebo in achieving remission in patients with active lupus nephritis

B. Rovin, S. Navarra, W. Pendergraft, 2022 .

Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index.

I. Bruce, D. Gladman, L. Magder, 2008, Arthritis and rheumatism.

Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response.

D. Gladman, L. Magder, B. Rovin, 2008, Arthritis and rheumatism.

Clinical and real-world evaluation of a fingernail selfie smartphone app for noninvasive, individually-personalized estimation of blood hemoglobin levels

R. Mannino, E. Tyburski, J. Whitson, 2022, medRxiv.

Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies

G. Remuzzi, J. Wetzels, G. Appel, 2022, American Journal of Nephrology.

Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan

G. Remuzzi, J. Wetzels, G. Appel, 2022, American Journal of Nephrology.

Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis

W. Winkelmayer, P. Zimetbaum, C. Herzog, 2021, Kidney international reports.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy

B. Rovin, C. Szeto, C. Sommerer, 2023, Kidney international reports.